Obesity, type 2 diabetes, elevated SBP accelerate progression of risk factors for vascular aging
WEDNESDAY, May 6, 2020 (HealthDay News) — The presence of obesity, type 2 diabetes, and elevated systolic blood pressure (SBP) in adolescence accelerates the progression of risk factors that play a role in the development of early vascular aging, according to a study published online May 6 in the Journal of the American Heart Association.
Justin R. Ryder, Ph.D., from the University of Minnesota Medical School in Minneapolis, and colleagues conducted a five-year longitudinal study among adolescents with normal weight, obesity, or type 2 diabetes at baseline (141, 156, and 151, respectively) to examine trajectories of early vascular aging.
The researchers found that participants with obesity had a greater positive change in common carotid intima media thickness (cIMT), bulb cIMT, internal cIMT, and carotid-femoral pulse wave velocity (PWV) compared with participants with normal weight; those with type 2 diabetes had a greater positive change in common cIMT, bulb cIMT, internal cIMT, augmentation index, and PWV carotid-femoral. There was an association between higher baseline SBP and greater positive change in common cIMT, bulb cIMT, internal cIMT, and PWV carotid-femoral.
“These data add further evidence underscoring the importance of efforts targeting prevention and treatment of obesity, type 2 diabetes, and elevated BP among youth with a goal of delaying and/or preventing the progression of early vascular aging,” the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Exercise-Based Cardiac Rehab Beneficial for Coronary Heart Disease
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists
Eating More Ultraprocessed Foods Heightens Risk for Chronic Diseases
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds
Oral Vitamin C Active in Clonal Cytopenia of Undetermined Significance
2009 to 2023 Saw Surge in Probiotic Supplement Use